SBWire

The dPCR and qPCR industry is expected to experience significant growth in the near future. This is due to the increasing demand for precise, accurate, and efficient detection of nucleic acids for various applications, such as gene expression analysis, disease diagnosis, and food safety testing. Furthermore, the development of highly sensitive and specific instruments, reagents, and assays for dPCR and qPCR are expected to drive the market growth. Additionally, the introduction of next-generation sequencing (NGS) methods, such as single-cell sequencing, is expected to further fuel the growth of the dPCR and qPCR industry. Moreover, the increasing demand for personalized medicine and rapid diagnostics is expected to create numerous opportunities for the dPCR and qPCR industry.

An investigation was announced for investors of Hywin Holdings Ltd. (NASDAQ: HYW) shares over potential securities laws violations by Hywin Holdings Ltd.

An investor, who purchased shares of Dada Nexus Limited (NASDAQ: DADA), filed a lawsuit against Dada Nexus Limited over alleged violations of Federal Securities Laws.

Applied Materials, Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Xponential Fitness, Inc is under investigation over potential securities laws violations in connection with certain financial statements.

An investigation was announced for investors of Waldencast plc (NASDAQ: WALD) shares over potential securities laws violations by Waldencast plc in connection with certain financial statements.